European Urology
@EUplatinum
Followers
41K
Following
610
Media
4K
Statuses
9K
The Platinum Journal | Official Journal of EAU @Uroweb | Ranked #1 in Urology & Nephrology | Editor in Chief @Albert0Briganti | IF 25.3
Joined April 2011
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 25.3, over 2 million website downloads, and 39.1k followers on Twitter we are constantly striving to be a cut above the rest! . Thank you to our Authors, Reviewers, and Readership!
1
18
73
We're proud to continue leading the charge in academic Urology: new impact factor 17.947. Thank you to all of our readers, authors, reviewers, and editors! .@JimCatto @Els_Urology
11
54
290
7
85
282
We and @Uroweb are delighted to announce that Alberto Briganti @Albert0Briganti will replace @JimCatto as our new Editor in Chief of @EUplatinum Thank you to all the team who worked so hard to take us this far and we look forward to new horizons.
31
35
266
New Platinum Editorial from @KBGinsburg @jpschober @uretericbud. Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?.
8
63
182
In loving memory of Urs Studer. Our thoughts are with his family, friends, and all who were touched by his remarkable contributions to Urology. Thank you for influencing urologists and how we practice urology today.
15
41
177
No difference in RFS, CSS or OS for Extended vs Limited Lymph Node Dissection in #bladdercancer Patients Undergoing Radical Cystectomy: A Prospective, Randomized Trial @TU_Muenchen @AStenzl .#blcsm #VisualAbstract .
9
149
171
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma. @Uroweb @Els_Urology .#eauguidelines.@MattMilowsky @MariaJRibal
2
93
172
We are DELIGHTED to welcome Dr. Sarah Psutka as the newest member of our Editorial team!. @spsutkaMD @uwurology @Uroweb @Els_Urology @SWIUorg
19
8
157
We are delighted to add @ERPlimackMD as our new Medical Oncology Editor!. Dr. Plimack is a Professor of Medical Oncology, Chief of the Division of Genitourinary Medical Oncology and Director of Genitourinary Clinical Research at @FoxChaseCancer .
9
25
153
January 2022 Issue. The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.
0
73
150
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401).#prostatecancer .
1
80
142
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.@JelleBarentsz @ProfPadhani .
0
80
147
Oligometastatic Bladder Cancer: Defining a Novel Entity . . @Chrislabaki1 @eddy_saad @DrChoueiri @OncoBellmunt . #bladdercancer
0
62
138
Best of 2020 Visual Abstracts.🏆1st Place🏆.#VisualAbstract .Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma Congrats! @BBhindi @sandysrimd @montypal @DrChoueiri @brian_rini @DrDanielHeng et al.
2
49
143
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.#VisualAbstract @Uroweb .@MRoupret @DrShariat @ThoSeisen @paolo_gontero @joanfundi @BPeyronnet .
4
75
142
Please join us in welcoming @piet_ost as our new Radiation Oncology Editor!. Dr. Ost is an associate professor at Ghent University and radiation oncologist at the Iridium Network, Antwerp, Belgium. @Uroweb @EurUrolOncol @EurUrolFocus @EurUrolOpen
18
20
139
The Role of Stereotactic Ablative Body Radiotherapy in RCC @_ShankarSiva @lawrentschuk @DrRanaMcKay . SABR: local control rate (LCR) >90% with Gr 3–4 toxicity 0–9%.LCR: 90%-97% in intracranial mRCC.SABR: delayed systemic Rx > 1 yr in 70–90% oligomet RCC
3
72
146
Updated @Uroweb Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.#VisualAbstract .@AlbigesL @Uromigos @MichaelStaehler .
1
98
144
Active Surveillance for Low-risk #ProstateCancer : The European Association of Urology Position in 2018 #VisualAbstract @Uroweb
0
98
134
Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations @zklaassen_md et al
2
97
131
MRI-targeted Biopsy Versus Systematic Biopsy in the Detection of #ProstateCancer - A Systematic Review and Meta-analysis.@veerukasi @mrsprostate @ArmandoStabile @jbriosaneves @EmbertonMark @giga_fra @deeksj @DrYPhilippou .#VisualAbstract #pcsm.
2
73
134
Incorporating PSMA PET in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer . . @LauraBukavinaMD @AmyLuckenbaugh @DrMHofman @sophia_kamran @declangmurphy @KOSJ12 @piet_ost
2
59
133
Epidemiology of Renal Cell Carcinoma: 2022 Update . . @LauraBukavinaMD @spsutkaMD @kbensalah35 @benchallacombe @WesKassouf. @tsoburol
1
49
131
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma.#VisualAbstract . @BBhindi @DrDanielHeng @DrChoueiri @montypal @brian_rini @ZiadBakouny @sandysrimd .
4
63
131
Reporting Radical Cystectomy Outcomes Following Implementation of ERAS Protocols: A Systematic Review and Individual Patient Data Meta-Analysis.#VisualAbstract.@SWilliams_MD @siadaneshmand @JimCatto @marcuskwesi @UroDocAsh @pcvblack @WesKassouf .
3
56
126
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology.#VisualAbstract.@VickersBiostats @f2harrell @statistishdan .
0
61
127
Structured Population-based Prostate-specific Antigen Screening for #ProstateCancer : The European Association of Urology Position in 2019
6
99
123
January 2021 Issue. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.@Uroweb #eauguidelines #VisualAbstract
2
57
126
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. @VHMeissner
15
47
125
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.@jleow @OncoBellmunt @tompowles1 .
2
66
123
Multiparametric Magnetic Resonance Imaging for #BladderCancer : Development of VI-RADS (Vesical Imaging-Reporting And Data System)
1
96
120
Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized #prostatecancer #visualabstract .@BrighamWomens .
4
101
118
Young Age on Starting PSA Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial . . @SigridCarlsson @VickersBiostats et al.
1
50
116
September 2020 Issue.Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines.
1
63
116
Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.#VisualAbstract.@UroOncMD @MichaelASJewett @dougcheung @FleshnerNeil @siemensr @marty_gleave @SiTanguay .
0
51
114
Randomized Phase III Trial of dd-MVAC, or GC as Perioperative Chemotherapy for Pts with MIBC. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses.#VisualAbstract.
0
75
104
August 2022 Issue. Radical Prostatectomy Without Prior Biopsy Following mpMRI and PSMA PET . Editorial: Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative?
13
45
112
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. @GottfridSjodahl @UroLiedberg . "Urothelial cancer of the luminal-like subtypes is more responsive to cisplatin-based neoadjuvant chemotherapy"
3
38
110
Prostate imaging may miss over half of all prostate tumors and up to a third of all clinically significant tumors
7
53
112
Stereotactic RT for Oligoprogression in mRCC Pts Receiving TKI Therapy: Phase 2 Prospective Multicenter Study.@sarehkeshavarzi @SahgalArjun ."Local control of irradiated oligoprogressive mRCC tumors was high; change in therapy was delayed for median >1 yr"
2
50
111
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update @Uroweb
2
65
111
Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails.
1
47
108
Although we're supposed to be in Amsterdam at EAU, #COVID19 won't stop the @EUplatinum editorial board from meeting!. First Virtual Editorial Board Meeting.@Uroweb #EAU20
4
17
108
Congratulations to @MaartenAlbersen on receiving the European Urology Platinum Award . #EAU23
13
5
103
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 23.4, over 2 million website downloads, and 36.7k followers on Twitter we are constantly striving to be a cut above the rest! . Thank you to our Authors, Reviewers, and Readership!
7
22
102
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.#VisualAbstract .@jeanlestingi @qdtrinh @RafaelFCoelho2
1
46
106
During another challenging year, we are incredibly grateful for the continued support of the Platinum Journal. Thank you to our Editors, Reviewers, and Readership!. @Uroweb @Els_Urology
3
23
106
Single-port Robotic Transvesical Partial Prostatectomy for Localized Prostate Cancer: Initial Series and Description of Technique . . @drjkaouk @EricKleinMD @Purysko @KavianiMd @mohameddmagdyy
5
21
100
The Microbiome and Genitourinary Cancer: A Collaborative Review
0
58
99
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines.@_alelarcher @u_capitanio @F_Montorsi @GFallara_MD @GianmarcoColand .
3
53
100
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).@EBMUrology @dr_coops .
1
59
101
Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial. @AbtDominik @daniel_engeler @GautierMuellhau
3
43
98
Online Professionalism—2018 Update of European Association of #Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media @HendrikBorgmann @JimCatto @uretericbud #eauguidelines #eau19 #SoMe.
0
73
100
New Words of Wisdom from @d_magee22 @uretericbud. Re: Adjuvant Pembrolizumab After Nephrectomy in Renal-cell Carcinoma.
2
32
100
Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.#VisualAbstract.@UroDocJT @michael_gorin #prostatecancer .
0
58
97
At this time each year, we thank our outstanding editors, reviewers, authors, support staff, and readers for making the Platinum Journal the premier Urology & Nephrology peer-reviewed journal. Thank you! .🙏🎆. @JimCatto @Els_Urology
3
19
94
Analysis of >2,000 bladder carcinoma shows 6 molecular subtypes with distinct pathways and targetable vulnerability
0
51
94
Normally, this time of year we would be celebrating.the announcement of our IF. This year is.different. Instead, we give thanks to everyone in the.European Urology community who continue to work.tirelessly during these difficult times.@EurUrolOncol @EurUrolFocus @EurUrolOpen
1
24
96
Highlight: Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors . . @IJubber @_SeanOng @LauraBukavinaMD @pcvblack @evacomperat @UroDocAsh @lawrentschuk @JoshMeeks @AndreaNecchi @VPanebiancoIT @ArianaZnaor @JimCatto @marcuskwesi
1
36
94
68Ga-PSMA-PET in Advanced #ProstateCancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of PSMA-avid Lesions: A Systematic Review and Meta-analysis.@drMPerera @declangmurphy @lawrentschuk @dan_christidis .#VisualAbstract #pcsm.
2
60
95
Head-to-head Comparison of TRUS Prostate Biopsy Versus mpMRI with Subsequent MR-guided Biopsy in Biopsy-naïve Men with Elevated PSA: A Large Prospective Multicenter Clinical Study @radboudumc #VisualAbstract.
3
58
92
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized PCa: An International Multidisciplinary Consensus.@AmirLebastchi @arvinkgeorge @ThomasPolascik @michael_gorin @RSanchezSalas @PChoyke .
1
48
94
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
1
56
90
New Research Letter: Short-course 177Lu-PSMA-617 Radioligand Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer: Time to Take the Leap?.
0
38
91
August 2020 Issue.What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort #VisualAbstract.Editorial:
2
38
89
Posterior, Anterior, and Periurethral Surgical Reconstruction of Urinary Continence Mechanisms in Robot-assisted Radical Prostatectomy: A Description and Video Compilation of Commonly Performed Surgical Techniques #ProstateCancer
0
62
89
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians. @amerseburger @scserendipity1 @MariaJRibal @SvenPerner @cnsternberg @quimmateo @ProfWirth @Dolmos77 @DanielPetrylak
1
38
87
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.@apccc19 @Silke_Gillessen @AOmlin @onco_uroloog @AlbertoBossial @Prof_IanD @mattsydes @ChrisSweens1 .#apccc19 #prostatecancer
0
48
87
We are pleased to announce that Todd Morgan has joined European Urology as an Associate Editor: Welcome to the team, Todd @wandering_gu
5
11
84
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on PCa—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent #VisualAbstract .@Uroweb @officialEANM @ESTRO_RT @EsurOffice @philcornford @marcuskwesi @Nicola_Fossati @Silke_Gillessen
0
54
82
Updated @Uroweb Guidelines on RCC: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic ccRCC.@Uromigos @MichaelStaehler @RachelGiles6 @milanhoraplzen @amerseburger .@foxal72 .#VisualAbstract #kcsm #kidneycancer
0
47
81
Medical Expulsive Therapy for Urinary Stones: Future Trends and Knowledge Gaps.@vdconinck @MattBultitude @JodiAntonelli @DrBenChew @SkolarikosAndre .#VisualAbstract .
2
37
84
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial.#VisualAbstract. @DrMHofman @jhsyim @mfrydenberg @lawrentschuk @declangmurphy
0
39
85
External Beam Radiotherapy Increases the Risk of #BladderCancer When Compared with Radical Prostatectomy in Patients Affected by #ProstateCancer : A Population-based Analysis @UroMoschini
7
79
83
MRI of the prostate has high negative predictive value, but biopsy cannot still be avoided after negative MRI
2
65
80
Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind Placebo-controlled Trial
4
85
83
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty .
3
54
80
First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis @WallisCJD et al
1
61
83
Video compilation of surgical techniques for urinary incontinence in RARP
1
28
80
Prevalence of and Predictive Factors for Burnout Among French Urologists in Training.@afufuro @BPeyronnet @jo_olivier85 @dimbdx @AkakpoWill @CLebacle @BenjaminPradere @xaviermatillon @inesdom40 @PavlosMD .#VisualAbstract #MedEd .
2
50
78
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.#VisualAbstract.@motzermd @cnsternberg @brian_rini @DrChoueiri @AStenzl
1
35
81
NPV of mpMRI in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.#VisualAbstract.@NiranjanJS @LambAlastair @JimCatto @declangmurphy @mrsprostate .
0
46
83
Duration of Androgen Deprivation Therapy in High-risk #ProstateCancer : A Randomized Phase III Trial #VisualAbstract
0
59
77
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.@Uroweb @GGandaglia .#VisualAbstract .
1
51
80
Platinum Priority - Prostate Cancer: Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer:
1
45
79
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. @Uroweb @AlbigesL @foxal72 @Yasminabugh @u_capitanio @DrDabestani @RachelGiles6 @milanhoraplzen @Dr_Klatte @Lorenzo_marconi @tompowles1
0
39
82
October 2020 Issue. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
1
41
80
New In Press.EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer @Uroweb @ESTRO_RT @EsurOffice @SIOGorg .@philcornford @Dr_Willemse @marcuskwesi @mdesantis234 @Nicola_Fossati
0
48
80
December 2021 Issue. The Additive Diagnostic Value of PSMA PET/CT to mpMRI Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study "PSMA + MRI improved NPV and sensitivity for csPCa in an MRI triaged population"
1
29
79
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes
1
72
78
Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. Read the full article here: . @aherlema @dr_coops. #UroSoMe #Medtwitter #PCa
1
36
77
Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial.#VisualAbstract.@HitenDPatel @allaf_mo @farzanafais @cpavmd @drphil_urology @michael_gorin @misophan @alan_partin .
0
32
78
The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial by Alexander Light et al. . #prostatecancer #Medtwitter #UroSoMe
1
30
77
March 2021 Issue. Updated EAU Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma.#VisualAbstract @Uroweb .#eauguidelines
0
37
78
Best Scientific Paper 2022: . Louise Emmett et al for their paper, "The Additive Diagnostic Value of Prostate-specific Membrane Antigen PET Computed Tomography to Multiparametric MRI Triage in the Diagnosis of PCa (PRIMARY): A Prospective Multicentre Study". Congratulations!
3
20
79